Current Drug Targets - Inflammation & Allergy

Continued as Inflammation & Allergy - Drug Targets

Personal Subscription
Volume: 2 Issue: 3, September

CpG Oligodeoxynucleotides: A Novel Therapeutic Approach For Atopic Disorders

Volume:2   Issue: 3
Pp: 199-205
Iftikhar Hussain and Joel N. Kline
DOI: 10.2174/1568010033484151
Published on: 01 March, 2012

Emerging Features in the Regulation of MMP-9 Gene Expression for the Development of Novel Molecular Targets and Therapeutic Strategies

Volume:2   Issue: 3
Pp: 206-215
Yves St-Pierre, Celine Van Themsche and Pierre-Olivier Esteve
DOI: 10.2174/1568010033484133
Published on: 01 March, 2012

Effects of Chrisotherapeutic Gold Compounds on Prostaglandin E2 Production

Volume:2   Issue: 3
Pp: 216-223
Masamichi Yamashita, Kazuo Ohuchi and Motoaki Takayanagi
DOI: 10.2174/1568010033484142
Published on: 01 March, 2012

Epithelial Cell-Derived Antibacterial Peptides Human β-Defensins and Cathelicidin: Multifunctional Activities on Mast Cells

Volume:2   Issue: 3
Pp: 224-231
Francois Niyonsaba, Michimasa Hirata, Hideoki Ogawa and Isao Nagaoka
DOI: 10.2174/1568010033484115
Published on: 01 March, 2012

Mechanisms Leading to Autoantibody Production: Link Between Inflammation and Autoimmunity

Volume:2   Issue: 3
Pp: 232-241
Hitoshi Ohmori and Naoki Kanayama
DOI: 10.2174/1568010033484124
Published on: 01 March, 2012

Inflammatory Mechanisms in Myocardial Infarction

Volume:2   Issue: 3
Pp: 242-256
Guofeng Ren, Oliver Dewald and Nikolaos G. Frangogiannis
DOI: 10.2174/1568010033484098
Published on: 01 March, 2012

Inflammatory Cytokines and Cardiovascular Disease

Volume:2   Issue: 3
Pp: 257-265
Takayuki Ito and Uichi Ikeda
DOI: 10.2174/1568010033484106
Published on: 01 March, 2012